News
A large number of hypertension patients may unknowingly suffer from primary aldosteronism (PA) — a common but underdiagnosed ...
With its demonstrated clinical benefits and superior selectivity profile, SC0062 is positioned to potentially become a ...
High blood pressure, also known as Hypertension, is a chronic, most life-long, irreversible condition in which the force of ...
Renal juxtaglomerular cells are the only known sites of renin production, and the kidney produces both renin and prorenin. 15 A number of extrarenal tissues, including the adrenal, ovary, testis, ...
Scientists at the University of Waterloo have found a possible danger when people take certain common drugs together. The ...
First- and second-generation potassium binders reduced potassium levels in a Swedish cohort of patients, despite premature ...
With only one medication historically used to treat diabetic kidney disease, study of combination therapies with newer ...
11d
InvestorsHub on MSNMineralys Therapeutics Shares Climb on Strong Results from Kidney Disease TrialShares of Mineralys Therapeutics Inc. (NASDAQ:MLYS) jumped 7.9% following the release of promising topline data from the ...
Investing.com -- Mineralys Therapeutics Inc (NASDAQ: MLYS) stock surged 7.9% after reporting positive topline data from its Phase 2 Explore-CKD trial for lorundrostat in patients with hypertension and ...
Discover how dehydration silently destroys kidney function. Learn the hidden dangers of chronic water shortage and protect ...
SGLT2 inhibitors have been shown to reduce risk of acute kidney injury, but whether kidney effects are modified by risk of acute dips in eGFR is unknown.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results